Department of Radiation Oncology

Transcriptomes of MPO-deficient patients with generalized pustular psoriasis reveals expansion of CD4+cytotoxic T cells and an involvement of complement system and interferon pathways (2021) Hüffmeier U, Frey B, Becker I, Atreya I, Berking C, Moessner R, Wilsmann-Theis D, et al. Conference contribution Chromosome aberrations in lymphocytes of patients undergoing radon spa therapy: An explorative mfish study (2021) Paz N, Hartel C, Nasonova E, Donaubauer AJ, Frey B, Ritter S Journal article Long‐term follow‐up of patients receiving neoadjuvant treatment modalties for soft tissue sarcomas of the extremities (2021) Rauch M, Agaimy A, Semrau S, Willner A, Ott O, Fietkau R, Hohenberger W, et al. Journal article Prognostic and predictive value of PD-L1 expression and tumour infiltrating lymphocytes (TiLs) in locally advanced NSCLC treated with simultaneous radiochemotherapy in the randomized, multicenter, phase III German Intergroup lung Trial (GILT) (2021) Tufman A, Neumann J, Manapov F, Sellmer L, Jung A, Kauffmann-Guerrero D, Kahnert K, et al. Journal article Treatment strategy by radioiodine refractory differentiated thyroid cancer (2021) Mantsopoulos K, Müller SK, Pavel ME, Kuwert T, Meidenbauer N, Fietkau R, Sievert M, Iro H Journal article Innovative radiation oncology Together - Precise, Personalized, Human Vision 2030 for radiotherapy & radiation oncology in Germany (2021) Krug D, Hecht M, Ebert N, Maeurer M, Fleischmann DF, Fokas E, Straube C, et al. Journal article Trends in radiotherapy inpatient admissions in Germany: a population-based study over a 10-year period (2021) Medenwald D, Fietkau R, Klautke G, Langer S, Wuerschmidt F, Vordermark D Journal article, Original article Patient-reported treatment satisfaction with Rivaroxaban in cancer patients with acute venous thromboembolism - Results from the CONKO-011 trial (2021) Sinn M, Juehling A, Hellmann M, Omar M, Suedhoff T, Stahl M, Krziwanie A, et al. Conference contribution ELDORANDO - Pembrolizumab compared with methotrexate in elderly, frail or cisplatin-ineligible patients with relapsed or metastatic squamous cell carcinoma of the head and neck (RM-SCCHN) (ELDORANDO-AIO-KHT-0115) (2021) Klinghammer K, Graeven U, Ivanyi P, Dietz A, Hahn D, Hackenberg S, Kasper S, et al. Conference contribution Ga-68-FAPI-04 PET/CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-related interstitial lung disease (2021) Schmidkonz C, Distler J, Treutlein C, Atzinger A, Prante O, Ritt P, Goetz T, et al. Journal article